Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTX110 via CED in Newly Diagnosed DIPG
NCT03566199Phase 2Completed
- Start
- May 2018
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MTX110 in diffuse intrinsic pontine glioma (DIPG). Started May 2018; status: completed.
02
Drugs
MTX110
03
Conditions
diffuse intrinsic pontine glioma (DIPG)
Beyond the preview
Go deeper on NCT03566199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03566199.